NextCure Competitors and Similar CompaniesClear all

NextCure's competitors and similar companies include Ayala Pharmaceuticals, Arvinas and Kite Pharma.

	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	Kite Pharma Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
Founding Date	Founding Date 2015	Founding Date 2017	Founding Date N/A	Founding Date 2009
Type	Type Public	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Healthcare Technology biotech drug development life sciences oncology pharma therapy	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations Beltsville, US HQ	Locations Wilmington, US HQ Rehovot, IL Wilmington, US	Locations New Haven, US HQ	Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more
Employees	Employees N/A	Employees 29	Employees 13329% increase	Employees 3,9671% decrease
Valuation ($)	Valuation ($) 39.2 m	Valuation ($) 7.4 m	Valuation ($) 1.9 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $692k (FY, 2022)	Revenue (est.) $262.6m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($55.8m) (FY, 2025)	Net income ($38m) (FY, 2022)	Net income ($80.8m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 160m	Total funding raised $ 47m	Total funding raised $ 111.6m	Total funding raised $ 85.3m